Group 1 - The core stock price of Beishimei increased by 2.07% on November 19, reaching 9.86 CNY per share, with a total market capitalization of 3.561 billion CNY [1] - The company experienced a stock price decline of 3.43% year-to-date, but saw a 1.75% increase over the last five trading days and a 2.28% increase over the last 20 days, while it dropped 19.51% over the last 60 days [2] - As of September 30, the number of shareholders decreased by 9.41% to 18,000, with an average of 20,046 circulating shares per person, which increased by 10.39% [2] Group 2 - Beishimei's main business includes the research, production, and sales of products such as 4-nitro intermediates, dimethenamid-p active ingredients, and dimethenamid-p formulations, with the main revenue sources being dimethenamid-p active ingredients (25.95%) and various trade pesticides [2] - For the period from January to September 2025, Beishimei achieved operating revenue of 1.11 billion CNY, representing a year-on-year growth of 14.29%, and a net profit attributable to shareholders of 31.17 million CNY, reflecting a significant year-on-year increase of 1257.94% [2] - The company has distributed a total of 62.87 million CNY in dividends since its A-share listing, with 38.52 million CNY distributed over the past three years [3]

Core Viewpoint - Beishimei, established in 2003 and listed in 2019, is a domestic pesticide company focusing on R&D, production, and sales, with a differentiated advantage across the entire industry chain [1] Group 1: Business Performance - In Q3 2025, Beishimei reported revenue of 1.11 billion yuan, ranking 23rd among 32 companies in the industry, with the industry leader, ADAMA, at 21.678 billion yuan [2] - The net profit for the same period was 28.547 million yuan, also ranking 23rd, while the industry leader, Yangnong Chemical, achieved a net profit of 1.056 billion yuan [2] Group 2: Financial Ratios - As of Q3 2025, Beishimei's debt-to-asset ratio was 45.47%, an increase from 42.14% year-on-year, but still below the industry average of 46.06% [3] - The gross profit margin for Q3 2025 was 17.44%, up from 14.40% year-on-year, yet lower than the industry average of 21.70% [3] Group 3: Executive Compensation - The chairman and general manager, Zhong Xijun, received a salary of 610,800 yuan in 2024, a slight increase from 608,500 yuan in 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 9.41% to 18,000, while the average number of circulating A-shares held per account increased by 10.39% to 20,000 [5]

Core Viewpoint - The company has successfully achieved stable production and bulk sales of its carbon five derivative products, including cyclopentane and pentene, while also progressing in the construction of specialty alcohols and maintaining global sales of dimethyl pentyl herbicide [2]. Group 1: Product Sales and Production - The cyclopentane series project has achieved stable production and bulk sales [2]. - Pentene, as a by-product of the ketone unit, has an annual production capacity of 4,000 tons, with normal production and sales ongoing [2]. Group 2: Project Development - The "20,000 tons per year specialty alcohol series green new materials project" has entered the construction phase and is progressing as planned [2]. Group 3: Global Sales - The company, through its wholly-owned subsidiary Ningbo Jielike, is conducting global sales of dimethyl pentyl herbicide, with product coverage expected to reach 79 countries and regions by 2024 [2].

Core Viewpoint - The company, Baismei, has established a comprehensive industrial chain in its self-produced pesticide business, covering pesticide intermediates, active ingredients, and formulations, emphasizing technology research and development as a key driver for growth [2] Group 1: Business Operations - The company has a complete system for research and development, intermediate production, active ingredient synthesis, and formulation processing [2] - Baismei focuses on independent research and development, supplemented by collaborative development, ensuring continuous transformation of research results into productivity [2] Group 2: Product Quality - The core process technology developed by the company supports its production in various segments, with the concentration and impurity levels of its dimethyl tetrachloride active ingredient meeting or exceeding the standards and requirements of developed countries [2] Group 3: Market Expansion - The subsidiary, Ningbo Jielike, has established sales channels in 79 countries and regions, enhancing the company's ability to expand into international markets through its independent registration model and channel resources [2]

Core Viewpoint - The company, Bestme (贝斯美), has the capability to become a qualified strategic supplier for multinational pesticide companies due to its comprehensive production capabilities and advanced technology in pesticide manufacturing [1] Group 1: Production Capabilities - The company has a complete industrial chain covering pesticide intermediates, active ingredients, and formulations, supported by its own research and development [1] - The core process technology developed by the company allows its products, such as dimethenamid-p, to meet or exceed the standards and requirements of developed countries [1] Group 2: Research and Development - The company emphasizes technology research and development, primarily focusing on independent research while also engaging in collaborative development [1] - The continuous transformation of research results into production capabilities is a key aspect of the company's strategy [1] Group 3: Market Expansion - The subsidiary, Ningbo Jielike, has established sales channels in 79 countries and regions, enhancing the company's ability to expand into international markets [1] - The company's self-registration model and channel resources provide a richer resource base for international market expansion [1]

Core Points - The company Baisimei (SZ 300796) announced an incentive plan on September 10, which will grant a total of 116 individuals restricted stock, sourced from shares repurchased in the secondary market [1] - The total number of restricted shares to be granted is up to 5.6 million, representing approximately 1.55% of the company's total share capital of about 361 million shares at the time of the announcement [1] - The grant price for the restricted shares is set at 5.65 yuan per share, allowing recipients to purchase the shares at this price upon meeting vesting conditions, with a maximum validity period of 48 months [1] - For the first half of 2025, Baisimei's revenue composition is entirely from pesticide intermediates and the active ingredient of dimethomorph, indicating a focused business model [1] - As of the report date, Baisimei's market capitalization stands at 3.7 billion yuan [1]

Group 1 - The company Beishimei (SZ 300796) announced that its 11th meeting of the 4th board of directors will be held on September 10, 2025, to discuss matters related to stock incentive plans [1] - For the first half of 2025, Beishimei's revenue composition is entirely from pesticide intermediates and the active ingredient Dimethenamid-P, accounting for 100% [1] - As of the report date, Beishimei has a market capitalization of 3.7 billion yuan [1]

Core Viewpoint - The stock of Beishimei experienced a decline of 2.02% on August 27, with a trading price of 11.17 yuan per share and a total market capitalization of 4.034 billion yuan, indicating a mixed performance in recent trading sessions [1]. Financial Performance - For the first half of 2025, Beishimei achieved operating revenue of 776 million yuan, representing a year-on-year growth of 16.57%. The net profit attributable to shareholders was 34.706 million yuan, showing a significant increase of 109.70% compared to the previous period [2]. - Since its A-share listing, Beishimei has distributed a total of 62.87 million yuan in dividends, with 38.52 million yuan distributed over the past three years [3]. Stock Market Activity - As of August 27, Beishimei's stock price has increased by 9.40% year-to-date, but it has seen a decline of 6.92% over the last five trading days. In the last 20 days, the stock rose by 3.71%, and in the last 60 days, it increased by 3.81% [1]. - The stock's trading volume on August 27 was 131 million yuan, with a turnover rate of 3.20%. The net outflow of main funds was 16.33 million yuan, with significant selling pressure observed [1]. Company Overview - Beishimei, established on March 31, 2003, and listed on November 15, 2019, is located in Shaoxing, Zhejiang Province. The company specializes in the research, production, and sales of various chemical products, primarily focusing on 4-nitro intermediates, dimethenamid-p active ingredients, and formulations [1]. - The revenue composition of Beishimei includes 25.95% from dimethenamid-p active ingredients, 25.54% from trade herbicides, 18.91% from trade insecticides, and other chemical products [1]. Shareholder Information - As of June 30, Beishimei had 19,900 shareholders, an increase of 82.96% from the previous period. The average number of tradable shares per shareholder decreased by 45.34% to 18,160 shares [2].

Group 1 - The company announced a provision for asset impairment amounting to 4.1417 million yuan, which will directly impact the net profit attributable to the parent company for the first half of 2025 [1][2] - As of the end of 2024, the revenue composition of the company is predominantly from pesticide intermediates and the active ingredient Dimethenamid-P, accounting for 99.94% of total revenue, with other businesses contributing only 0.06% [1][2] - The company conducted a comprehensive review and impairment testing of its assets, including accounts receivable, other receivables, and inventory, to ensure a true and fair view of its financial position as of June 30, 2025 [2]

Core Viewpoint - The company has established a complete industrial chain layout for pesticide production, ensuring stable production capacity and readiness to meet increased market demand due to severe drought and flooding conditions this year [1] Production Capacity Summary - The company has disclosed its production capacity in the 2024 annual report, detailing the following: - Pesticide intermediates have a designed capacity of 23,000 tons per year, with a current utilization rate of 62.34% [1] - Dimethenamid-P active ingredient has a designed capacity of 12,000 tons per year, with a current utilization rate of 76.76% [1] - Dimethenamid-P formulation has a designed capacity of 4,000 kiloliters per year, with a current utilization rate of 53.85% [1] - The existing production capacity and technological reserves of the company can support a rapid response to market demand growth [1]